Impact of Surgical and Immunological Parameters in Pediatric Liver Transplantation
- 1 February 2004
- journal article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 239 (2) , 272-280
- https://doi.org/10.1097/01.sla.0000108681.24374.02
Abstract
To assess the respective impact of surgical and immunologic factors on patient/graft outcome and rejection after pediatric liver transplantation. Orthotopic liver transplantation (OLT) constitutes a validated therapeutic modality for acute liver failure and end-stage liver disease in children. Only a few large studies of factors influencing outcome of pediatric OLT are available in the literature. Studies considering the impact of rejection on graft outcome are scarce in adult OLT and are not even available for pediatric recipients. Five hundred consecutive pediatric recipients (<15 years) of a primary OLT performed between March 1984 and July 2000 were retrospectively reviewed. The main indication was biliary atresia (n = 328). A living related donor graft was used from July 1993 onwards in 82 children (16%). Survival was calculated and multivariate analysis was performed. Actuarial survival rates at 1, 5, and 10 years were 85%, 81%, and 79% for patients, and 76%, 71%, and 70% for grafts, respectively. At the multivariate analysis, only 3 factors were found to be independently correlated with better patient survival: year of transplantation (P = 0.001), pretransplant diagnosis (P < 0.001, worst results for liver tumors), and ABO matching (P < 0.001, worst results for ABO incompatibility). Similarly, 3 factors were independently correlated with better rejection-free graft survival: tacrolimus as primary immunosuppressant (P < 0.001), a negative T-cell crossmatch (P = 0.016), and younger age of the donor (P < 0.001). Pediatric OLT constitutes a complex undertaking with multifactorial impact on results: (1). a strong learning curve effect was shown to impact on overall results; (2). pediatric liver tumors still represent a challenging indication for OLT; (3). primary immunoprophylaxis with tacrolimus provided a lower rejection incidence; (4). the younger donor age effect deserves further immunologic investigations.Keywords
This publication has 24 references indexed in Scilit:
- Management of the pediatric liver transplant patientLiver Transplantation, 2001
- STUDIES OF PEDIATRIC LIVER TRANSPLANTATION (SPLIT): YEAR 2000 OUTCOMESTransplantation, 2001
- Pediatric liver transplantation with cadaveric or living related donors: Comparative results in 90 elective recipients of primary graftsThe Journal of Pediatrics, 1999
- Long-Term Results of Pediatric Liver TransplantationAnnals of Surgery, 1998
- A POSITIVE CROSSMATCH IN LIVER TRANSPLANTATION-NO EFFECT OR INAPPROPRIATE ANALYSIS?Transplantation, 1997
- Living donor liver transplantation: ethical considerationsJournal of Hepatology, 1996
- PROPHYLACTIC IMMUNOSUPPRESSION WITH ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL ANTIBODY LO-TACT-1 VERSUS OKT3 IN LIVER ALLOGRAFTINGTransplantation, 1996
- HLA COMPATIBILITY AND LIVER TRANSPLANT OUTCOME Improved Patient Survival by HLA and Cross-MatchingTransplantation, 1994
- Liver transplantation in children less than 1 year of ageThe Journal of Pediatrics, 1990
- Biopsy findings in cases of rejection of liver allograft.Journal of Clinical Pathology, 1985